SetPoint Medical said today it raised $30 million in a Series D equity financing round with funds slated to support continued development of its bioelectronic therapy for treating chronic inflammatory diseases. Funding in the round came from existing investors including NEA, Morgenthaler, Medtronic (NYSE:MDT), Boston Scientific (NYSE:BSX), Topspin, Action Potential Venture Capital, the Valencia, Calif.-based company said. “We […]
SetPoint Medical
Acelity taps Jokinen as CFO, exec VP | Personnel Moves June 20, 2017
Acelity said last week it tapped Tracy Jokinen as its chief financial officer and executive vice president, taking over for interim CFO Todd Wyatt. Jokinen was formerly a CFO of uniform and facility services provider G&K services, which was acquired by Cintas earlier this year. Prior to working at G&K, Jokinen spent more than 20 years at […]
New Enterprise Associates gets in on SetPoint Medical
SetPoint Medical said today that it has received an investment from venture capital firm New Enterprise Associates. SetPoint is developing a neuromodulation device designed to stimulate the vagus nerve to trigger the body’s anti-inflammatory response, according to the company. Newly vested NEA joins existing investors Medtronic (NYSE:MDT), Boston Scientific (NYSE:BSX), GlaxoSmithKline‘s (NYSE:GSK) Action Potential Venture Capital […]
SetPoint adds $15m to Series C, gets backing by GlaxoSmithKline
SetPoint said today it raised $15 million in an extension of its Series C round of equity financing and added GlaxoSmithKline (NYSE:GSK)’s Action Potential Venture Capital to its list of investors. The funds from the round are slated to support clinical trials of the company’s bioelectronic therapy for treating rheumatoid arthritis and Crohn’s Disease and […]
Boston Scientific, Covidien get in on SetPoint Medical’s $27M round
SetPoint Medical said Boston Scientific (NYSE:BSX) and Covidien (NYSE:COV) were among the participants in a $27 million funding round.